Nutex Health Inc.
NUTXNasdaq
$162.98
↓ -0.9%Jul 17 close · end-of-day
Price
1Y↑ +56.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.2B
Enterprise Value
$1.0B
P/E
11.9
P/S
1.3
P/B
3.4
EV/EBITDA
3.4
PEG
—
FCF Yield
23.0%
Dividend Yield
—
Revenue (TTM)
$880.0M
Net Income (TTM)
$96.4M
Free Cash Flow (TTM)
$269.0M
Gross Margin
47.5%
Operating Margin
31.4%
Net Margin
10.9%
ROE
27.8%
ROIC
118.0%
Debt / Equity
0.1
Net Cash
$166.4M
Return 1Y
+47.1%
Company profile
Nutex Health, Inc. operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states.
- CEO
- Thomas T. Vo
- Sector
- Services
- Industry
- Business Services
- Employees
- 1,150
- Headquarters
- Texas
- Website
- nutexhealth.com
Management & directors
- Vo Thomas T.Chief Executive Officer
- Hosseinion WarrenPresident
- Montgomery Pamela W.Chief Legal Officer-Healthcare
- Bates Jon ChristianChief Financial Officer
- Chang Michael L.Chief Medical Officer
- Luqman Elisa VChief Legal Officer - SEC
Roles derived from SEC Form 4 filings.
Earnings
NUTX Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$216.5M↑ +2.2%
Diluted EPS$6.52↑ +95.8%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $274.0M | $331.5M | $219.3M | $247.6M | $479.9M | $875.3M |
| Gross profit | $157.6M | $179.3M | $15.4M | $34.8M | $196.3M | $444.3M |
| Operating income | $153.2M | $170.3M | -$406.6M | -$31.8M | $130.7M | $275.6M |
| Net income | $106.0M | $132.6M | -$424.8M | -$45.8M | $52.1M | $70.8M |
| Diluted EPS | $0.18 | $0.22 | -$100.36 | -$10.39 | $9.69 | $10.48 |
| Operating cash flow | $86.7M | $173.4M | $50.6M | $1.3M | $23.2M | $248.1M |
| Free cash flow | $25.5M | $136.5M | $36.0M | -$8.2M | $20.8M | $245.6M |
| Gross margin | 57.5% | 54.1% | 7.0% | 14.0% | 40.9% | 50.8% |
| Operating margin | 55.9% | 51.4% | -185.4% | -12.8% | 27.2% | 31.5% |
| Net margin | 38.7% | 40.0% | -193.7% | -18.5% | 10.9% | 8.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $76.1M | $78.8M | $257.6M | $211.8M | $244.0M | $267.8M | $151.7M | $216.5M |
| Gross profit | $22.6M | $21.9M | $141.6M | $118.3M | $124.9M | $154.9M | $46.1M | $91.7M |
| Operating income | $5.3M | $9.7M | $114.2M | $80.7M | $33.7M | $130.4M | $30.9M | $81.3M |
| Net income | -$364,000.00 | -$8.8M | $61.7M | $21.2M | -$17.7M | $55.4M | $11.8M | $46.8M |
| Diluted EPS | -$0.07 | -$1.72 | $11.12 | $3.33 | -$2.95 | $7.76 | $2.34 | $6.52 |
| Operating cash flow | $13.3M | $6.8M | $54,000.00 | $51.0M | $27.3M | $99.5M | $70.4M | $75.5M |
| Free cash flow | $12.7M | $6.2M | -$341,000.00 | $50.9M | $26.5M | $99.2M | $69.0M | $74.3M |
| Gross margin | 29.7% | 27.8% | 55.0% | 55.9% | 51.2% | 57.8% | 30.4% | 42.4% |
| Operating margin | 7.0% | 12.3% | 44.3% | 38.1% | 13.8% | 48.7% | 20.4% | 37.5% |
| Net margin | -0.5% | -11.2% | 23.9% | 10.0% | -7.3% | 20.7% | 7.8% | 21.6% |
Company news
May 4, 2026
- 77d agoNutex Health NUTX Q2 2025 Earnings Transcriptfool.com
- 77d agoExplore These 3 Undervalued Small Caps With Insider Buying Across Regionsfinance.yahoo.com
- 77d agoNutex Health And 2 Other Undiscovered Gems In The US Marketfinance.yahoo.com
- 77d agoA Look At Nutex Health (NUTX) Valuation After Strong Q1 2026 Results And New Buyback Programfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-04 | Spears Kelvin | J | 2,519 | $0.00 | $0.00 | filing |
| 2026-05-28 | Vo Thomas T.· Chief Executive Officer | J | 75,747 | $0.00 | $0.00 | filing |
| 2026-04-09 | Vo Thomas T.· Chief Executive Officer | J | 184,071 | $0.00 | $0.00 | filing |
| 2026-03-20 | Jaumot Frank E | Buy | 150 | $93.56 | $14,033.25 | filing |
| 2026-03-19 | Hosseinion Warren· President | Buy | 252 | $94.07 | $23,706.22 | filing |
| 2026-03-17 | Spears Kelvin | Buy | 10 | $94.46 | $944.60 | filing |
| 2026-03-13 | Montgomery Pamela W.· Chief Legal Officer-Healthcare | Buy | 79 | $88.87 | $7,020.72 | filing |
| 2026-03-10 | Hosseinion Warren· President | Tax withholding | 3,274 | $86.22 | $282,292.14 | filing |
| 2026-03-10 | Vo Thomas T.· Chief Executive Officer | Tax withholding | 3,017 | $86.22 | $260,132.98 | filing |
| 2026-03-10 | Luqman Elisa V· Chief Legal Officer - SEC | Tax withholding | 784 | $86.22 | $67,598.36 | filing |
| 2026-03-10 | Montgomery Pamela W.· Chief Legal Officer-Healthcare | Tax withholding | 776 | $86.22 | $66,908.58 | filing |
| 2026-03-10 | Chang Michael L.· Chief Medical Officer | Tax withholding | 769 | $86.22 | $66,305.03 | filing |
| 2026-03-10 | Spears Kelvin | Tax withholding | 82 | $86.22 | $7,070.24 | filing |
| 2026-03-10 | Hosseinion Warren· President | Option exercise | 6,293 | $0.00 | $0.00 | filing |
| 2026-03-10 | Montgomery Pamela W.· Chief Legal Officer-Healthcare | Option exercise | 2,084 | $0.00 | $0.00 | filing |
| 2026-03-10 | Vo Thomas T.· Chief Executive Officer | Option exercise | 8,334 | $0.00 | $0.00 | filing |
| 2026-03-10 | Luqman Elisa V· Chief Legal Officer - SEC | Option exercise | 2,084 | $0.00 | $0.00 | filing |
| 2026-03-10 | Bates Jon Christian· Chief Financial Officer | Option exercise | 2,667 | $0.00 | $0.00 | filing |
| 2026-03-10 | Spears Kelvin | Option exercise | 183 | $0.00 | $0.00 | filing |
| 2026-03-10 | Chang Michael L.· Chief Medical Officer | Option exercise | 2,084 | $0.00 | $0.00 | filing |
| 2025-11-25 | Bates Jon Christian· Chief Financial Officer | Buy | 750 | $136.71 | $102,532.43 | filing |
Latest 21 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.